메뉴 건너뛰기




Volumn 6, Issue 8, 2010, Pages

Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMOUS AGENTS; CELL CULTURE; CELL PROLIFERATION; COMPUTATION THEORY; COMPUTATIONAL METHODS; DYNAMICS; GENE TRANSFER; LIFE CYCLE; VIRUSES;

EID: 78049429450     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000883     Document Type: Article
Times cited : (16)

References (90)
  • 1
    • 50449090525 scopus 로고    scopus 로고
    • An HIV Vaccine- Challenges and Prospects
    • Johnston MI, Fauci AS (2008) An HIV Vaccine- Challenges and Prospects. N Engl J Med 359: 888-890.
    • (2008) N Engl J Med , vol.359 , pp. 888-890
    • Johnston, M.I.1    Fauci, A.S.2
  • 3
    • 1442355578 scopus 로고    scopus 로고
    • HIV Drug Resistance
    • Clavel F, Hance AJ (2004) HIV Drug Resistance. N Engl J Med 350: 1023-1035.
    • (2004) N Engl J Med , vol.350 , pp. 1023-1035
    • Clavel, F.1    Hance, A.J.2
  • 6
    • 34247208235 scopus 로고    scopus 로고
    • Transfer of Autologous Gene-modified T Cells in HIV-infected Patients with Advanced Immunodeficiency and Drug-resistant Virus
    • van Lunzen J, Glaunsinger T, Stahmer I, Baehr Vv, Baum C, et al. (2007) Transfer of Autologous Gene-modified T Cells in HIV-infected Patients with Advanced Immunodeficiency and Drug-resistant Virus. Mol Ther 15: 1024-1033.
    • (2007) Mol Ther , vol.15 , pp. 1024-1033
    • van Lunzen, J.1    Glaunsinger, T.2    Stahmer, I.3    Baehr, V.V.4    Baum, C.5
  • 7
    • 24944441656 scopus 로고    scopus 로고
    • Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals
    • Morgan RA, Walker R, Carter CS, Natarajan V, Tavel JA, et al. (2005) Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals. Hum Gene Ther 16: 1065-1074.
    • (2005) Hum Gene Ther , vol.16 , pp. 1065-1074
    • Morgan, R.A.1    Walker, R.2    Carter, C.S.3    Natarajan, V.4    Tavel, J.A.5
  • 8
    • 33745943955 scopus 로고    scopus 로고
    • Can gene delivery close the door to HIV-1 entry after escape?
    • Swan CH, Torbett BE (2006) Can gene delivery close the door to HIV-1 entry after escape? J Med Primatol 35: 236-247.
    • (2006) J Med Primatol , vol.35 , pp. 236-247
    • Swan, C.H.1    Torbett, B.E.2
  • 9
    • 1242319384 scopus 로고    scopus 로고
    • Human Immunodeficiency Virus Type 1 Escapes from RNA Interference- Mediated Inhibition
    • Das AT, Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, et al. (2004) Human Immunodeficiency Virus Type 1 Escapes from RNA Interference- Mediated Inhibition. J Virol 78: 2601-2605.
    • (2004) J Virol , vol.78 , pp. 2601-2605
    • Das, A.T.1    Brummelkamp, T.R.2    Westerhout, E.M.3    Vink, M.4    Madiredjo, M.5
  • 10
    • 65349113010 scopus 로고    scopus 로고
    • Mutations in gp120 Contribute to the Resistance of Human Immunodeficiency Virus Type 1 to Membrane-Anchored C-Peptide maC46
    • Hermann FG, Egerer L, Brauer F, Gerum C, Schwalbe H, et al. (2009) Mutations in gp120 Contribute to the Resistance of Human Immunodeficiency Virus Type 1 to Membrane-Anchored C-Peptide maC46. J Virol 83: 4844-4853.
    • (2009) J Virol , vol.83 , pp. 4844-4853
    • Hermann, F.G.1    Egerer, L.2    Brauer, F.3    Gerum, C.4    Schwalbe, H.5
  • 11
    • 2942639506 scopus 로고    scopus 로고
    • Antisense- Mediated Inhibition of Human Immunodeficiency Virus (HIV) Replication by Use of an HIV Type 1-Based Vector Results in Severely Attenuated Mutants Incapable of Developing Resistance
    • Lu X, Yu Q, Binder GK, Chen Z, Slepushkina T, et al. (2004) Antisense- Mediated Inhibition of Human Immunodeficiency Virus (HIV) Replication by Use of an HIV Type 1-Based Vector Results in Severely Attenuated Mutants Incapable of Developing Resistance. J Virol 78: 7079-7088.
    • (2004) J Virol , vol.78 , pp. 7079-7088
    • Lu, X.1    Yu, Q.2    Binder, G.K.3    Chen, Z.4    Slepushkina, T.5
  • 12
    • 33751001588 scopus 로고    scopus 로고
    • Silencing of HIV-1 with RNA interference: A multiple shRNA approach
    • ter Brake O, Konstantinova P, Ceylan M, Berkhout B (2006) Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 14: 883-892.
    • (2006) Mol Ther , vol.14 , pp. 883-892
    • Ter Brake, O.1    Konstantinova, P.2    Ceylan, M.3    Berkhout, B.4
  • 13
    • 27744605569 scopus 로고    scopus 로고
    • Long-Term Inhibition of HIV- 1 Infection in Primary Hematopoietic Cells by Lentiviral Vector Delivery of a Triple Combination of Anti-HIV shRNA, Anti-CCR5 Ribozyme, and a Nucleolar-Localizing TAR Decoy
    • Li M-J, Kim J, Li S, Zaia J, Yee J-K, et al. (2005) Long-Term Inhibition of HIV- 1 Infection in Primary Hematopoietic Cells by Lentiviral Vector Delivery of a Triple Combination of Anti-HIV shRNA, Anti-CCR5 Ribozyme, and a Nucleolar-Localizing TAR Decoy. Mol Ther 12: 900-909.
    • (2005) Mol Ther , vol.12 , pp. 900-909
    • Li, M.-J.1    Kim, J.2    Li, S.3    Zaia, J.4    Yee, J.-K.5
  • 14
    • 34447094733 scopus 로고    scopus 로고
    • Progress and prospects: RNA-based therapies for treatment of HIV infection
    • Scherer L, Rossi JJ, Weinberg MS (2007) Progress and prospects: RNA-based therapies for treatment of HIV infection. Gene Ther 14: 1057-1064.
    • (2007) Gene Ther , vol.14 , pp. 1057-1064
    • Scherer, L.1    Rossi, J.J.2    Weinberg, M.S.3
  • 17
    • 0036371443 scopus 로고    scopus 로고
    • Modelling viral and immune system dynamics
    • Perelson AS (2002) Modelling viral and immune system dynamics. Nat Rev Immun 2: 28-36.
    • (2002) Nat Rev Immun , vol.2 , pp. 28-36
    • Perelson, A.S.1
  • 18
    • 0035102156 scopus 로고    scopus 로고
    • Transition between stochastic evolution and deterministic evolution in the presence of selection: General theory and application to virology
    • Rouzine IM, Rodrigo A, Coffin JM (2001) Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology. Microbiol Mol Biol Rev 65: 151-185.
    • (2001) Microbiol Mol Biol Rev , vol.65 , pp. 151-185
    • Rouzine, I.M.1    Rodrigo, A.2    Coffin, J.M.3
  • 19
    • 0031177754 scopus 로고    scopus 로고
    • Gene therapy of T helper cells in HIV infection: Mathematical model of the criteria for clinical effect
    • Lund O, Lund O, Gram G, Nielsen S, Schanning K, et al. (1997) Gene therapy of T helper cells in HIV infection: Mathematical model of the criteria for clinical effect. Bull Math Biol 59: 725-745.
    • (1997) Bull Math Biol , vol.59 , pp. 725-745
    • Lund, O.1    Lund, O.2    Gram, G.3    Nielsen, S.4    Schanning, K.5
  • 20
    • 0141570489 scopus 로고    scopus 로고
    • Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection
    • Weinberger LS, Schaffer DV, Arkin AP (2003) Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection. J Virol 77: 10028-10036.
    • (2003) J Virol , vol.77 , pp. 10028-10036
    • Weinberger, L.S.1    Schaffer, D.V.2    Arkin, A.P.3
  • 21
    • 28444441312 scopus 로고    scopus 로고
    • Impact of gene-modified T cells on HIV infection dynamics
    • von Laer D, Hasselmann S, Hasselmann K (2006) Impact of gene-modified T cells on HIV infection dynamics. J Theor Biol 238: 60-77.
    • (2006) J Theor Biol , vol.238 , pp. 60-77
    • von Laer, D.1    Hasselmann, S.2    Hasselmann, K.3
  • 22
    • 13744250051 scopus 로고    scopus 로고
    • Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape
    • Leonard JN, Schaffer DV (2005) Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J Virol 79: 1645-1654.
    • (2005) J Virol , vol.79 , pp. 1645-1654
    • Leonard, J.N.1    Schaffer, D.V.2
  • 23
    • 55249098418 scopus 로고    scopus 로고
    • HIV evades RNA interference directed at TAR by an indirect compensatory mechanism
    • Leonard JN, Shah PS, Burnett JC, Schaffer DV (2008) HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host Microbe 4: 484-494.
    • (2008) Cell Host Microbe , vol.4 , pp. 484-494
    • Leonard, J.N.1    Shah, P.S.2    Burnett, J.C.3    Schaffer, D.V.4
  • 24
    • 33745646047 scopus 로고    scopus 로고
    • Gene-Based Immunotherapy for Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
    • Dropulic B, June CH (2006) Gene-Based Immunotherapy for Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome. Hum Gene Ther 17: 577-588.
    • (2006) Hum Gene Ther , vol.17 , pp. 577-588
    • Dropulic, B.1    June, C.H.2
  • 26
    • 48749086685 scopus 로고    scopus 로고
    • Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment-Naive Populations and Associate with Reduced Treatment Efficacy
    • Johnson JA, Li J-F, Wei X, Lipscomb J, Irlbeck D, et al. (2008) Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment-Naive Populations and Associate with Reduced Treatment Efficacy. PLoS Med 5: e158.
    • (2008) PLoS Med , vol.5
    • Johnson, J.A.1    Li, J.-F.2    Wei, X.3    Lipscomb, J.4    Irlbeck, D.5
  • 27
    • 41849144119 scopus 로고    scopus 로고
    • Updated prevalence of genotypic resistance among HIV-1 positive patients naïve to antiretroviral therapy: A single center analysis
    • Lapadula G, Izzo I, Gargiulo F, Paraninfo G, Castelnuovo F, et al. (2008) Updated prevalence of genotypic resistance among HIV-1 positive patients naïve to antiretroviral therapy: a single center analysis. J Med Virol 80: 747-753.
    • (2008) J Med Virol , vol.80 , pp. 747-753
    • Lapadula, G.1    Izzo, I.2    Gargiulo, F.3    Paraninfo, G.4    Castelnuovo, F.5
  • 28
    • 34548779028 scopus 로고    scopus 로고
    • Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in nonhuman primates
    • An DS, Donahue RE, Kamata M, Poon B, Metzger M, et al. (2007) Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in nonhuman primates. Proc Natl Acad Sci U S A 104: 13110-13115.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 13110-13115
    • An, D.S.1    Donahue, R.E.2    Kamata, M.3    Poon, B.4    Metzger, M.5
  • 29
    • 27344445600 scopus 로고    scopus 로고
    • CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection
    • Anderson J, Akkina R (2005) CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection. Retrovirology 2: 53.
    • (2005) Retrovirology , vol.2 , pp. 53
    • Anderson, J.1    Akkina, R.2
  • 30
    • 46949095221 scopus 로고    scopus 로고
    • Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
    • Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, et al. (2008) Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26: 808-816.
    • (2008) Nat Biotechnol , vol.26 , pp. 808-816
    • Perez, E.E.1    Wang, J.2    Miller, J.C.3    Jouvenot, Y.4    Kim, K.A.5
  • 31
    • 33745941234 scopus 로고    scopus 로고
    • T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery
    • Swan CH, Buhler B, Tschan MP, Barbas CF, III, Torbett BE (2006) T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery. Gene Ther 13: 1480-1492.
    • (2006) Gene Ther , vol.13 , pp. 1480-1492
    • Swan, C.H.1    Buhler, B.2    Tschan, M.P.3    Barbas III, C.F.4    Torbett, B.E.5
  • 32
    • 20044385229 scopus 로고    scopus 로고
    • Tcell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120
    • Masiero S, Del Vecchio C, Gavioli R, Mattiuzzo G, Cusi MG, et al. (2004) Tcell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120. Gene Ther 12: 299-310.
    • (2004) Gene Ther , vol.12 , pp. 299-310
    • Masiero, S.1    Del Vecchio, C.2    Gavioli, R.3    Mattiuzzo, G.4    Cusi, M.G.5
  • 33
    • 33745800238 scopus 로고    scopus 로고
    • Removal of Arginine 332 Allows Human TRIM5a To Bind Human Immunodeficiency Virus Capsids and To Restrict Infection
    • Li Y, Li X, Stremlau M, Lee M, Sodroski J (2006) Removal of Arginine 332 Allows Human TRIM5a To Bind Human Immunodeficiency Virus Capsids and To Restrict Infection. J Virol 80: 6738-6744.
    • (2006) J Virol , vol.80 , pp. 6738-6744
    • Li, Y.1    Li, X.2    Stremlau, M.3    Lee, M.4    Sodroski, J.5
  • 34
    • 70349438847 scopus 로고    scopus 로고
    • Engineering lymphocyte subsets: Tools, trials and tribulations
    • June CH, Blazar BR, Riley JL (2009) Engineering lymphocyte subsets: tools, trials and tribulations. Nat Rev Immunol 9: 704-716.
    • (2009) Nat Rev Immunol , vol.9 , pp. 704-716
    • June, C.H.1    Blazar, B.R.2    Riley, J.L.3
  • 35
    • 61849091496 scopus 로고    scopus 로고
    • Adoptive immunotherapy: Good habits instilled at youth have long-term benefits
    • Paulos C, Suhoski M, Plesa G, Jiang T, Basu S, et al. (2008) Adoptive immunotherapy: good habits instilled at youth have long-term benefits. Immunol Res 42: 182-196.
    • (2008) Immunol Res , vol.42 , pp. 182-196
    • Paulos, C.1    Suhoski, M.2    Plesa, G.3    Jiang, T.4    Basu, S.5
  • 36
    • 77955608799 scopus 로고    scopus 로고
    • Safety and feasibility of lentiviral vector-modified CD34+ cells in the setting of autologous transplantation for AIDS-related lymphoma
    • 36ra43
    • DiGiusto DL, Krishnan A, Li L, Li H, Li S, et al. (2010) Safety and feasibility of lentiviral vector-modified CD34+ cells in the setting of autologous transplantation for AIDS-related lymphoma. Sci Transl Med 2: 36ra43.
    • (2010) Sci Transl Med , vol.2
    • DiGiusto, D.L.1    Krishnan, A.2    Li, L.3    Li, H.4    Li, S.5
  • 37
    • 0028982445 scopus 로고
    • Towards a general function describing t cell proliferation
    • De Boer RJ, Perelson AS (1995) Towards a general function describing t cell proliferation. J Theor Biol 175: 567-576.
    • (1995) J Theor Biol , vol.175 , pp. 567-576
    • De Boer, R.J.1    Perelson, A.S.2
  • 38
    • 0029967721 scopus 로고    scopus 로고
    • HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
    • Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582-1586.
    • (1996) Science , vol.271 , pp. 1582-1586
    • Perelson, A.S.1    Neumann, A.U.2    Markowitz, M.3    Leonard, J.M.4    Ho, D.D.5
  • 39
    • 68949196315 scopus 로고    scopus 로고
    • Modeling HIV persistence, the latent reservoir, and viral blips
    • Rong L, Perelson AS (2009) Modeling HIV persistence, the latent reservoir, and viral blips. J Theor Biol 260: 308-331.
    • (2009) J Theor Biol , vol.260 , pp. 308-331
    • Rong, L.1    Perelson, A.S.2
  • 40
    • 1842613542 scopus 로고    scopus 로고
    • HIV-1 dynamics in vivo: Implications for therapy
    • Simon V, Ho DD (2003) HIV-1 dynamics in vivo: implications for therapy. Nat Rev Microbiol 1: 181-190.
    • (2003) Nat Rev Microbiol , vol.1 , pp. 181-190
    • Simon, V.1    Ho, D.D.2
  • 41
    • 74349091890 scopus 로고    scopus 로고
    • Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo
    • Kiem H-P, Wu RA, Sun G, von Laer D, Rossi JJ, et al. (2010) Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo. Gene Ther 17: 37-49.
    • (2010) Gene Ther , vol.17 , pp. 37-49
    • Kiem, H.-P.1    Wu, R.A.2    Sun, G.3    von Laer, D.4    Rossi, J.J.5
  • 42
    • 33745258996 scopus 로고    scopus 로고
    • Gene therapy for HIV infection: What does it need to make it work?
    • von Laer D, Hasselmann S, Hasselmann K (2006) Gene therapy for HIV infection: what does it need to make it work? J Gene Med 8: 658-667.
    • (2006) J Gene Med , vol.8 , pp. 658-667
    • von Laer, D.1    Hasselmann, S.2    Hasselmann, K.3
  • 43
    • 9144270207 scopus 로고    scopus 로고
    • Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides
    • Egelhofer M, Brandenburg G, Martinius H, Schult-Dietrich P, Melikyan G, et al. (2004) Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides. J Virol 78: 568-575.
    • (2004) J Virol , vol.78 , pp. 568-575
    • Egelhofer, M.1    Brandenburg, G.2    Martinius, H.3    Schult-Dietrich, P.4    Melikyan, G.5
  • 44
    • 64049093511 scopus 로고    scopus 로고
    • Protein Scaffold and Expression Level Determine Antiviral Activity of Membrane-Anchored Antiviral Peptides
    • Hermann FG, Martinius H, Egelhofer M, Giroglou T, Tonn T, et al. (2009) Protein Scaffold and Expression Level Determine Antiviral Activity of Membrane-Anchored Antiviral Peptides. Hum Gene Ther 20: 325-336.
    • (2009) Hum Gene Ther , vol.20 , pp. 325-336
    • Hermann, F.G.1    Martinius, H.2    Egelhofer, M.3    Giroglou, T.4    Tonn, T.5
  • 45
    • 1642424244 scopus 로고    scopus 로고
    • Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty
    • Murray JM, Kaufmann GR, Hodgkin PD, Lewin SR, Kelleher AD, et al. (2003) Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty. Immunol Cell Biol 81: 487-495.
    • (2003) Immunol Cell Biol , vol.81 , pp. 487-495
    • Murray, J.M.1    Kaufmann, G.R.2    Hodgkin, P.D.3    Lewin, S.R.4    Kelleher, A.D.5
  • 47
    • 0035575775 scopus 로고    scopus 로고
    • Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection
    • Douek DC, Betts MR, Hill BJ, Little SJ, Lempicki R, et al. (2001) Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection. J Immunol 167: 6663-6668.
    • (2001) J Immunol , vol.167 , pp. 6663-6668
    • Douek, D.C.1    Betts, M.R.2    Hill, B.J.3    Little, S.J.4    Lempicki, R.5
  • 48
    • 0028812436 scopus 로고
    • Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy
    • Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, et al. (1995) Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy. N Engl J Med 332: 143-149.
    • (1995) N Engl J Med , vol.332 , pp. 143-149
    • Mckall, C.L.1    Fleisher, T.A.2    Brown, M.R.3    Andrich, M.P.4    Chen, C.C.5
  • 49
    • 0343963783 scopus 로고    scopus 로고
    • Effect of Deleterious Mutation- Accumulation on the Fitness of RNA Bacteriophage MS2
    • Pena Mdl, Elena SF, Moya A (2000) Effect of Deleterious Mutation- Accumulation on the Fitness of RNA Bacteriophage MS2. Evolution 54: 686-691.
    • (2000) Evolution , vol.54 , pp. 686-691
    • Pena, M.D.L.1    Elena, S.F.2    Moya, A.3
  • 51
    • 0037022396 scopus 로고    scopus 로고
    • Redundancy, antiredundancy, and the robustness of genomes
    • Krakauer DC, Plotkin JB (2002) Redundancy, antiredundancy, and the robustness of genomes. Proc Natl Acad Sci U S A 99: 1405-1409.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 1405-1409
    • Krakauer, D.C.1    Plotkin, J.B.2
  • 52
    • 0347319126 scopus 로고    scopus 로고
    • Competitive Fitness of Nevirapine-Resistant Human Immunodeficiency Virus Type 1 Mutants
    • Collins JA, Thompson MG, Paintsil E, Ricketts M, Gedzior J, et al. (2004) Competitive Fitness of Nevirapine-Resistant Human Immunodeficiency Virus Type 1 Mutants. J Virol 78: 603-611.
    • (2004) J Virol , vol.78 , pp. 603-611
    • Collins, J.A.1    Thompson, M.G.2    Paintsil, E.3    Ricketts, M.4    Gedzior, J.5
  • 54
    • 25144487293 scopus 로고    scopus 로고
    • Selection and characterization of HIV-1 showing reduced susceptibility to the nonpeptidic protease inhibitor tipranavir
    • Doyon L, Tremblay S, Bourgon L, Wardrop E, Cordingley MG (2005) Selection and characterization of HIV-1 showing reduced susceptibility to the nonpeptidic protease inhibitor tipranavir. Antiviral Res 68: 27-35.
    • (2005) Antiviral Res , vol.68 , pp. 27-35
    • Doyon, L.1    Tremblay, S.2    Bourgon, L.3    Wardrop, E.4    Cordingley, M.G.5
  • 55
    • 0030926277 scopus 로고    scopus 로고
    • Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215
    • Goudsmit J, de Ronde A, de Rooij E, de Boer R (1997) Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215. J Virol 71: 4479-4484.
    • (1997) J Virol , vol.71 , pp. 4479-4484
    • Goudsmit, J.1    de Ronde, A.2    de Rooij, E.3    de Boer, R.4
  • 56
    • 0034469260 scopus 로고    scopus 로고
    • Estimating relative fitness in viral competition experiments
    • Maree AFM, Keulen W, Boucher CAB, De Boer RJ (2000) Estimating relative fitness in viral competition experiments. J Virol 74: 11067-11072.
    • (2000) J Virol , vol.74 , pp. 11067-11072
    • Maree, A.F.M.1    Keulen, W.2    Boucher, C.A.B.3    De Boer, R.J.4
  • 57
    • 33144469071 scopus 로고    scopus 로고
    • Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay
    • Wu H, Huang Y, Dykes C, Liu D, Ma J, et al. (2006) Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay. J Virol 80: 2380-2389.
    • (2006) J Virol , vol.80 , pp. 2380-2389
    • Wu, H.1    Huang, Y.2    Dykes, C.3    Liu, D.4    Ma, J.5
  • 58
    • 35448985039 scopus 로고    scopus 로고
    • Clinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness
    • Dykes C, Demeter LM (2007) Clinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness. Clin Microbiol Rev 20: 550-578.
    • (2007) Clin Microbiol Rev , vol.20 , pp. 550-578
    • Dykes, C.1    Demeter, L.M.2
  • 59
    • 0037309716 scopus 로고    scopus 로고
    • Barriers to nonviral gene delivery
    • Wiethoff CM, Middaugh CR (2003) Barriers to nonviral gene delivery. J Pharm Sci 92: 203-217.
    • (2003) J Pharm Sci , vol.92 , pp. 203-217
    • Wiethoff, C.M.1    Middaugh, C.R.2
  • 60
    • 33645162202 scopus 로고    scopus 로고
    • Antiviral RNAi therapy: Emerging approaches for hitting a moving target
    • Leonard JN, Schaffer DV (2005) Antiviral RNAi therapy: emerging approaches for hitting a moving target. Gene Ther 13: 532-540.
    • (2005) Gene Ther , vol.13 , pp. 532-540
    • Leonard, J.N.1    Schaffer, D.V.2
  • 61
    • 33748438866 scopus 로고    scopus 로고
    • Optimization and Functional Effects of Stable Short Hairpin RNA Expression in Primary Human Lymphocytes via Lentiviral Vectors
    • An DS, Qin FX-F, Auyeung VC, Mao SH, Kung SKP, et al. (2006) Optimization and Functional Effects of Stable Short Hairpin RNA Expression in Primary Human Lymphocytes via Lentiviral Vectors. Mol Ther 14: 494-504.
    • (2006) Mol Ther , vol.14 , pp. 494-504
    • An, D.S.1    Qin, F.X.-F.2    Auyeung, V.C.3    Mao, S.H.4    Kung, S.K.P.5
  • 62
    • 60749101528 scopus 로고    scopus 로고
    • Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ T cells modifies adoptively transferred T-cell function in cis
    • Rowley J, Monie A, Hung C-F, Wu T-C (2009) Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ T cells modifies adoptively transferred T-cell function in cis. Eur J Immunol 39: 491-506.
    • (2009) Eur J Immunol , vol.39 , pp. 491-506
    • Rowley, J.1    Monie, A.2    Hung, C.-F.3    Wu, T.-C.4
  • 63
    • 0346727524 scopus 로고    scopus 로고
    • MicroRNAs Modulate Hematopoietic Lineage Differentiation
    • Chen C-Z, Li L, Lodish HF, Bartel DP (2004) MicroRNAs Modulate Hematopoietic Lineage Differentiation. Science 303: 83-86.
    • (2004) Science , vol.303 , pp. 83-86
    • Chen, C.-Z.1    Li, L.2    Lodish, H.F.3    Bartel, D.P.4
  • 64
    • 8444237735 scopus 로고    scopus 로고
    • Genetic Manipulation of Telomerase in HIV-Specific CD8+ T Cells: Enhanced Antiviral Functions Accompany the Increased Proliferative Potential and Telomere Length Stabilization
    • Dagarag M, Evazyan T, Rao N, Effros RB (2004) Genetic Manipulation of Telomerase in HIV-Specific CD8+ T Cells: Enhanced Antiviral Functions Accompany the Increased Proliferative Potential and Telomere Length Stabilization. J Immunol 173: 6303-6311.
    • (2004) J Immunol , vol.173 , pp. 6303-6311
    • Dagarag, M.1    Evazyan, T.2    Rao, N.3    Effros, R.B.4
  • 65
    • 28244460980 scopus 로고    scopus 로고
    • Primary Human T Lymphocytes Engineered with a Codon-Optimized IL-15 Gene Resist Cytokine Withdrawal-Induced Apoptosis and Persist Long-Term in the Absence of Exogenous Cytokine
    • Hsu C, Hughes MS, Zheng Z, Bray RB, Rosenberg SA, et al. (2005) Primary Human T Lymphocytes Engineered with a Codon-Optimized IL-15 Gene Resist Cytokine Withdrawal-Induced Apoptosis and Persist Long-Term in the Absence of Exogenous Cytokine. J Immunol 175: 7226-7234.
    • (2005) J Immunol , vol.175 , pp. 7226-7234
    • Hsu, C.1    Hughes, M.S.2    Zheng, Z.3    Bray, R.B.4    Rosenberg, S.A.5
  • 66
    • 21344439665 scopus 로고    scopus 로고
    • Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT
    • Roth A, Baerlocher GM, Schertzer M, Chavez E, Duhrsen U, et al. (2005) Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT. Blood 106: 43-50.
    • (2005) Blood , vol.106 , pp. 43-50
    • Roth, A.1    Baerlocher, G.M.2    Schertzer, M.3    Chavez, E.4    Duhrsen, U.5
  • 67
    • 33745299723 scopus 로고    scopus 로고
    • Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
    • Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, et al. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441: 537-541.
    • (2006) Nature , vol.441 , pp. 537-541
    • Grimm, D.1    Streetz, K.L.2    Jopling, C.L.3    Storm, T.A.4    Pandey, K.5
  • 68
    • 34548548614 scopus 로고    scopus 로고
    • Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC
    • Castanotto D, Sakurai K, Lingeman R, Li H, Shively L, et al. (2007) Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucl Acids Res 35: 5154-5164.
    • (2007) Nucl Acids Res , vol.35 , pp. 5154-5164
    • Castanotto, D.1    Sakurai, K.2    Lingeman, R.3    Li, H.4    Shively, L.5
  • 70
    • 0037180499 scopus 로고    scopus 로고
    • In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4+ but not CD8+ T cells depleted?
    • Ribeiro RM, Mohri H, Ho DD, Perelson AS (2002) In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4+ but not CD8+ T cells depleted? Proc Natl Acad Sci U S A 99: 15572-15577.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 15572-15577
    • Ribeiro, R.M.1    Mohri, H.2    Ho, D.D.3    Perelson, A.S.4
  • 71
    • 62049083710 scopus 로고    scopus 로고
    • Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
    • Mitsuyasu RT, Merigan TC, Carr A, Zack JA, Winters MA, et al. (2009) Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells. Nat Med 15: 285-292.
    • (2009) Nat Med , vol.15 , pp. 285-292
    • Mitsuyasu, R.T.1    Merigan, T.C.2    Carr, A.3    Zack, J.A.4    Winters, M.A.5
  • 72
    • 33344476395 scopus 로고    scopus 로고
    • Survival of the fittest: In vivo selection and stem cell gene therapy
    • Neff T, Beard BC, Kiem H-P (2006) Survival of the fittest: in vivo selection and stem cell gene therapy. Blood 107: 1751-1760.
    • (2006) Blood , vol.107 , pp. 1751-1760
    • Neff, T.1    Beard, B.C.2    Kiem, H.-P.3
  • 73
    • 77949424638 scopus 로고    scopus 로고
    • Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O6-methylguanine-DNA methyltransferaseP140K
    • Maier P, Spier I, Laufs S, Veldwijk MR, Fruehauf S, et al. (2010) Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O6-methylguanine-DNA methyltransferaseP140K. Gene Ther 17: 389-399.
    • (2010) Gene Ther , vol.17 , pp. 389-399
    • Maier, P.1    Spier, I.2    Laufs, S.3    Veldwijk, M.R.4    Fruehauf, S.5
  • 74
    • 70449427961 scopus 로고    scopus 로고
    • Protection of Stem Cell-Derived Lymphocytes in a Primate AIDS Gene Therapy Model after In Vivo Selection
    • Trobridge GD, Wu RA, Beard BC, Chiu SY, Muñz NM, et al. (2009) Protection of Stem Cell-Derived Lymphocytes in a Primate AIDS Gene Therapy Model after In Vivo Selection. PLoS One 4: e7693.
    • (2009) PLoS One , vol.4
    • Trobridge, G.D.1    Wu, R.A.2    Beard, B.C.3    Chiu, S.Y.4    Muñz, N.M.5
  • 75
    • 34548034889 scopus 로고    scopus 로고
    • Building an HIV-Proof Immune System
    • Cohen J (2007) Building an HIV-Proof Immune System. Science 317: 612-614.
    • (2007) Science , vol.317 , pp. 612-614
    • Cohen, J.1
  • 76
    • 1042291295 scopus 로고    scopus 로고
    • Recombination in HIV and the evolution of drug resistance: For better or for worse?
    • Bretscher MT, Althaus CL, Müller V, Bonhoeffer S (2004) Recombination in HIV and the evolution of drug resistance: for better or for worse? Bioessays 26: 180-188.
    • (2004) Bioessays , vol.26 , pp. 180-188
    • Bretscher, M.T.1    Althaus, C.L.2    Müller, V.3    Bonhoeffer, S.4
  • 77
    • 63549107608 scopus 로고    scopus 로고
    • Timing the emergence of resistance to anti-HIV drugs with large genetic barriers
    • Arora P, Dixit NM (2009) Timing the emergence of resistance to anti-HIV drugs with large genetic barriers. PLoS Comput Biol 5: e1000305.
    • (2009) PLoS Comput Biol , vol.5
    • Arora, P.1    Dixit, N.M.2
  • 78
    • 29244441185 scopus 로고    scopus 로고
    • Hematopoietic Stem Cell Transduction and Amplification in Large Animal Models
    • Trobridge G, Beard BC, Kiem H-P (2005) Hematopoietic Stem Cell Transduction and Amplification in Large Animal Models. Hum Gene Ther 16: 1355-1366.
    • (2005) Hum Gene Ther , vol.16 , pp. 1355-1366
    • Trobridge, G.1    Beard, B.C.2    Kiem, H.-P.3
  • 80
    • 0036672918 scopus 로고    scopus 로고
    • Maintaining the norm: T-cell homeostasis
    • Jameson SC (2002) Maintaining the norm: T-cell homeostasis. Nat Rev Immunol 2: 547-556.
    • (2002) Nat Rev Immunol , vol.2 , pp. 547-556
    • Jameson, S.C.1
  • 81
    • 42149131535 scopus 로고    scopus 로고
    • Comprehensive Assessment and Mathematical Modeling of T Cell Population Dynamics and Homeostasis
    • Thomas-Vaslin V, Altes HK, de Boer RJ, Klatzmann D (2008) Comprehensive Assessment and Mathematical Modeling of T Cell Population Dynamics and Homeostasis. J Immunol 180: 2240-2250.
    • (2008) J Immunol , vol.180 , pp. 2240-2250
    • Thomas-Vaslin, V.1    Altes, H.K.2    de Boer, R.J.3    Klatzmann, D.4
  • 82
    • 25144493560 scopus 로고    scopus 로고
    • T Lymphocytes Transduced with a Lentiviral Vector Expressing F12-vif Are Protected from HIV-1 Infection in an APOBEC3G-Independent Manner
    • Vallanti G, Lupo R, Federico M, Mavilio F, Bovolenta C (2005) T Lymphocytes Transduced with a Lentiviral Vector Expressing F12-vif Are Protected from HIV-1 Infection in an APOBEC3G-Independent Manner. Mol Ther 12: 697-706.
    • (2005) Mol Ther , vol.12 , pp. 697-706
    • Vallanti, G.1    Lupo, R.2    Federico, M.3    Mavilio, F.4    Bovolenta, C.5
  • 83
    • 0028811974 scopus 로고
    • Viral dynamics in human immunodeficiency virus type 1 infection
    • Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, et al. (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122.
    • (1995) Nature , vol.373 , pp. 117-122
    • Wei, X.1    Ghosh, S.K.2    Taylor, M.E.3    Johnson, V.A.4    Emini, E.A.5
  • 84
    • 0030952479 scopus 로고    scopus 로고
    • Decay characteristics of HIV-1-infected compartments during combination therapy
    • Perelson AS, Essunger P, Cao YZ, Vesanen M, Hurley A, et al. (1997) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387: 188-191.
    • (1997) Nature , vol.387 , pp. 188-191
    • Perelson, A.S.1    Essunger, P.2    Cao, Y.Z.3    Vesanen, M.4    Hurley, A.5
  • 85
    • 0034608864 scopus 로고    scopus 로고
    • Production of resistant HIV mutants during antiretroviral therapy
    • Ribeiro RM, Bonhoeffer S (2000) Production of resistant HIV mutants during antiretroviral therapy. Proc Natl Acad Sci U S A 97: 7681-7686.
    • (2000) Proc Natl Acad Sci U S A , vol.97 , pp. 7681-7686
    • Ribeiro, R.M.1    Bonhoeffer, S.2
  • 86
    • 34547567775 scopus 로고    scopus 로고
    • Optimal timing and duration of induction therapy for HIV-1 infection
    • Curlin ME, Iyer S, Mittler JE (2007) Optimal timing and duration of induction therapy for HIV-1 infection. PLoS Comput Biol 3: 1239-1256.
    • (2007) PLoS Comput Biol , vol.3 , pp. 1239-1256
    • Curlin, M.E.1    Iyer, S.2    Mittler, J.E.3
  • 87
    • 33750338185 scopus 로고    scopus 로고
    • Genotypic Changes in Human Immunodeficiency Virus Type 1 Protease Associated with Reduced Susceptibility and Virologic Response to the Protease Inhibitor Tipranavir
    • Baxter JD, Schapiro JM, Boucher CAB, Kohlbrenner VM, Hall DB, et al. (2006) Genotypic Changes in Human Immunodeficiency Virus Type 1 Protease Associated with Reduced Susceptibility and Virologic Response to the Protease Inhibitor Tipranavir. J Virol 80: 10794-10801.
    • (2006) J Virol , vol.80 , pp. 10794-10801
    • Baxter, J.D.1    Schapiro, J.M.2    Boucher, C.A.B.3    Kohlbrenner, V.M.4    Hall, D.B.5
  • 88
    • 0033589745 scopus 로고    scopus 로고
    • Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
    • Ramratnam B, Bonhoeffer S, Binley J, Hurley A, Zhang L, et al. (1999) Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354: 1782-1785.
    • (1999) Lancet , vol.354 , pp. 1782-1785
    • Ramratnam, B.1    Bonhoeffer, S.2    Binley, J.3    Hurley, A.4    Zhang, L.5
  • 89
    • 0029075130 scopus 로고
    • Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase
    • Mansky L, Temin H (1995) Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 69: 5087-5094.
    • (1995) J Virol , vol.69 , pp. 5087-5094
    • Mansky, L.1    Temin, H.2
  • 90
    • 17444379333 scopus 로고    scopus 로고
    • Directly measured kinetics of circulating T lymphocytes in normal and HIV-1- infected humans
    • Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, et al. (1999) Directly measured kinetics of circulating T lymphocytes in normal and HIV-1- infected humans. Nat Med 5: 83-89.
    • (1999) Nat Med , vol.5 , pp. 83-89
    • Hellerstein, M.1    Hanley, M.B.2    Cesar, D.3    Siler, S.4    Papageorgopoulos, C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.